The new science of hormone replacement therapy

Menopause International

Volumn 5, Issue , 1999, Pages 4-5

  Dey, Michael ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84990353958     PISSN: 17540453     EISSN: None     Source Type: Journal    
DOI: 10.1177/13621807990050S201     Document Type: Article

References (10)

1. Roman R, et al, Identification of estrogens isolated from pregnant mares' urine. Can J. Pharmaceutical Sci 1975; 10: 8–11.
2. Klein R. The Composition of Premarin. Int J Fertil Women's Med 1998; 43: 223.
3. Grese TA, Dodge JA. Selective estrogen receptor modulators (SERMs). Current Pharmaceutical Design 1998; 4: 71–92.
4. Paech K, et al, Differential ligand activation of estrogen receptors. Science, 1997; 277: 1508–1510.
5. Dodge JA, et al, International Congress of Endocrinology 1996 San Francisco, CA [abstract] p. 249.
6. Bhavnani BR, et al, Biologic effects of delta-8-estrone sulfate in postmenopausal women. J Soc Gynecol Invest 1998; 5: 156–160.
7. Baracat E, et al, Estrogen activity and novel tissue selectivity of delta 8,9 dehydroestrone sulfate in postmenopausal women, J Clin Endocrinol Metab 1999. In press
8. Kuiper G, et al. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA, 1996; 93: 5925–30.
9. McDonnell DP, et al. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 1995; 9: 659–69.
10. Onate SA. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995; 270: 1354–1357.